Magnendo
1 known investors
Magnendo develops a magnetically steerable soft-robotic guidewire system for neurovascular endovascular procedures, enabling physicians to access hard-to-reach targets in the brain's blood vessels for stroke and aneurysm treatment. The system is designed to reduce procedural time, complications, and costs while improving patient outcomes.
Founders & leadership
YK
Yoonho KimPresident, CEO and Secretary
XZ
Xuanhe ZhaoDirector
JA
Jeffrey ArnoldChairman and Treasurer
AP
Aman PatelChief Medical Officer
MR
Meir RosenbergChief Development Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$18MraisedJul 2026 · 10 investors · BiotechnologyRule 506(b)
▶$18MraisedJul 2026 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yoonho KimExecutive Officer, Director
- Aman PatelDirector
- Jeffrey ArnoldDirector
- Xuanhe ZhaoDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$2.3MraisedOct 2024 · 37 investors · Other TechnologyRule 506(b)
▶$2.3MraisedOct 2024 · 37 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yoonho KimExecutive Officer, Director
- Xuanhe ZhaoDirector
- Jeffrey ArnoldExecutive Officer, Director
- Aman PatelExecutive Officer, Director
- Meir RosenbergExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $2.3M
- Proceeds to insiders
- $465K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.